Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation

Christopher S Gondi1, Neelima Kandhukuri, Shakuntala Kondraganti

  • 1Program of Cancer Biology, Department of Biomedical and Therapeutic Sciences, University of Illinois College of Medicine at Peoria, Peoria, IL 61656, USA.

Insights

Simultaneously down-regulating urokinase plasminogen activator receptor (uPAR) and cathepsin B inhibits glioma cell migration and causes cytoskeletal changes. Targeting both uPAR and cathepsin B shows potential for treating malignant gliomas.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Cathepsin B and urokinase plasminogen activator receptor (uPAR) are implicated in cancer cell migration and invasion.
  • Understanding their combined role is crucial for developing targeted therapies for malignant gliomas.

Purpose of the Study:

  • To investigate the effects of simultaneous uPAR and cathepsin B down-regulation on glioma cell migration and cytoskeletal dynamics.
  • To explore the underlying molecular mechanisms, including cofilin dephosphorylation, integrin expression, and key signaling pathways.

Main Methods:

  • Small interfering RNA (siRNA) for targeted gene down-regulation.
  • Western blotting to assess protein levels (cofilin, alphaVbeta3 integrin, ERK1/2, pERK1/2, p38MAPK, p-p38MAPK, AKT, pAKT, PI3-k).
  • Flow cytometry (FACS) analysis for alphaVbeta3 integrin expression.
  • Cytoskeleton studies to observe morphological changes.

Main Results:

  • Simultaneous uPAR and cathepsin B down-regulation significantly inhibited glioma cell migration and induced cytoskeletal condensation.
  • uPAR down-regulation led to decreased alphaVbeta3 integrin heterodimer levels.
  • Inhibition of MEK and PI3-k signaling pathways was observed.
  • Cofilin dephosphorylation was significantly affected by the combined down-regulation of uPAR and cathepsin B.

Conclusions:

  • uPAR plays a significant role in regulating cytoskeletal dynamics in glioma cells.
  • Combined targeting of uPAR and cathepsin B offers a promising therapeutic strategy for malignant gliomas.
  • The study highlights the intricate interplay between uPAR, cathepsin B, and cytoskeletal regulation in cancer progression.

Related Concept Videos

Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...